Pheochromocytoma is a very uncommon tumor that arises from the adrenal glands, which are small triangular glands located above each kidney. The adrenal glands manufacture essential hormones that control critical body functions, including blood pressure, metabolism, heart rate, and the response to stress. A pheochromocytoma develops from chromaffin cells, which produce two important catecholamines: adrenaline (epinephrine) and noradrenaline (norepinephrine).
In normal circumstances, these hormones are secreted in emergencies to trigger the "fight or flight" response. However, pheochromocytoma patients are exposed to uncontrolled hormone secretion because the excess amounts of hormones are produced by the tumors in their bodies. The effects of this disorder are hypertension accompanied by other symptoms.
Most pheochromocytomas are benign tumors that do not spread beyond their original site, but they still lead to severe health issues because they produce excessive hormone levels. In some cases, the tumor may be malignant and spread to other parts of the body. Uncontrolled hypertension needs early diagnosis and treatment to stop people from developing heart disease or stroke, or organ damage, which results from their condition.
Pheochromocytoma management has reached new heights through advances in imaging, hormonal assessment, surgical interventions, and extended patient follow-up. Patients who receive medical treatment reach excellent health outcomes.
The adrenal glands belong to the body"s endocrine system. Each person normally has two adrenal glands, one located above each kidney. The glands contain two primary sections, which include:
Pheochromocytoma originates exclusively from the adrenal medulla. The tumor cells continuously produce catecholamines, but without proper control, resulting in excessive hormone levels in the bloodstream.
The hormones affect multiple organs and tissues, leading to diverse symptoms in patients with pheochromocytoma.
Doctors do not always understand what causes pheochromocytoma to develop in patients. The tumor usually appears without any known cause in most patients who develop the condition. Certain genetic and hereditary diseases are known to increase the risk of developing this tumor.
Research indicates that inherited genetic mutations account for 30-40% of all cases of pheochromocytoma. The mutations affect genes that regulate cell growth and hormone production.
People with certain inherited disorders have an increased risk of developing pheochromocytoma. The following conditions belong to this group:
The people who have these hereditary conditions will develop tumors that will affect multiple endocrine glands in their bodies.
Pheochromocytoma can affect people of all ages, but doctors most commonly diagnose it in adults between the ages of 30 and 50 years.
People with a family history of pheochromocytoma or related genetic conditions may have an increased risk.
Pheochromocytoma symptoms result from excessive catecholamine production. Hormones affect three main systems: the heart and blood vessels, and the nervous system.
Patients with pheochromocytoma experience sudden symptom episodes, which doctors call "attacks" or "spells," which serve as a main characteristic of their condition.
The most common symptom of this condition is extreme or persistent elevated blood pressure. Some patients experience continuous hypertension, while others have sudden spikes in blood pressure during attacks.
Intense headaches are frequently reported during hormone surges.
The patients experience heart palpitations, and their heart rhythm becomes irregular while their heart rate increases.
People can develop sudden episodes of excessive sweating that occur without any physical activity.
The patients experience strong anxiety and nervousness, together with a feeling of future disaster, which they endure during their episodes.
The condition produces additional symptoms, which include:
These symptoms can begin suddenly or develop over minutes to hours. They occur either on their own or due to physical exercise, stress, specific medications, or surgical procedures.
Doctors rely on laboratory and imaging examinations to confirm whether a patient has pheochromocytoma.
The first step in the process involves analyzing blood and urine samples to determine catecholamine and metabolite concentrations. Below are some of the tests conducted:
Patients with elevated levels exhibit strong evidence for having a catecholamine-producing tumor.
Imaging studies are necessary after biochemical tests confirm the presence of pheochromocytoma to pinpoint the tumor location. The possible imaging techniques include the following:
The medical professionals use these imaging methods to measure the tumor's size, determine its position, and assess its potential to invade surrounding tissues.
The medical team decides to conduct genetic testing because hereditary mutations account for most cases, which affect patients who are younger or have a family history of endocrine tumors.
Most pheochromocytomas occur in the adrenal glands, but similar tumors can develop elsewhere. These tumors are known as paragangliomas. The majority of pheochromocytomas remain within the adrenal gland, but a small percentage spreads to other parts of the body. The most common body areas for tumor spread include:
The evaluation process assesses tumor advancement to guide appropriate treatment selection.
The primary method for treating pheochromocytoma involves surgical procedures to remove the existing tumor. The medical team needs to conduct extensive surgical preparations to eliminate risks from hormone-related complications.
Patients receive preoperative treatment, which includes blood pressure medications and catecholamine effect blockers, before their surgical procedures. The medication options include the following:
The process helps stabilize blood pressure, reducing the risk of severe complications during surgical operations.
Surgical procedures that remove tumors provide the best treatment results. Adrenalectomy represents a surgical procedure that removes the adrenal gland. The surgical approach to remove tumors depends on their dimensions and placement, which allows for two options:
Successful tumor extraction results in either major symptom relief or complete symptom disappearance.
The medical team requires further treatment options when the tumor shows malignant characteristics or has metastasized to different body regions. The medical team can proceed with the following treatment options:
The medical treatments aim to limit tumor growth while controlling associated symptoms.
Pheochromocytoma develops severe health risks when patients remain untreated and experience continuous high catecholamine levels. The procedure may result in the following health risks:
The medical team can reduce complication rates by promptly diagnosing and initiating treatment.
Patients need continuous monitoring after successful surgery because some will have a recurrence of their pheochromocytoma condition. The follow-up process involves three main activities:
Patients who have hereditary syndromes need continuous medical evaluation for their entire lives.
The prognosis for pheochromocytoma shows favorable results when doctors identify tumors at their early stage and execute complete tumor excision. Surgery provides significant symptom relief for most patients. The treatment needs for malignant tumor patients and genetic syndrome patients will continue until their condition stabilizes. The development of targeted therapies, together with improved diagnostic tools, has led to better health outcomes for these patient groups.
Tender Palm Super-Speciality Hospital offers advanced Pheochromocytoma treatment in Lucknow, India, at an affordable cost. We have a team of experienced endocrine surgeons and oncology specialists who provide accurate diagnosis and both non-surgical and surgical treatment options including laparoscopic adrenalectomy, medication management, and comprehensive hormonal monitoring procedures. Our Endocrine Surgery and Oncology team has decades of experience in successfully treating Pheochromocytoma in Lucknow, India.
Call us at +91-9076972161
Email at care@tenderpalm.com